546 search results for “bart cancer metastasis” in the Staff website
-
Bart Krans speaker at international seminar in Norway
Bart Krans, Professor of Private Law and Civil Procedure, spoke about ‘procedural agreements and ex officio application of EU law’ at an international seminar that was held at the University of Bergen in June. The results of the seminar will be published in 2023.
-
Bart Custers on EenVandaag about investigative powers of civilians
Social media are playing a key role in calling for resistance to the corona measures. Online, agreements are made about where and when people will gather to protest. The authorities are not always fully aware of what is happening and cannot just infiltrate, whereas civilians can often easily participate…
-
Bart Schuurman appointed Professor of terrorism and political violence
Terrorism expert Bart Schuurman has been appointed professor. As a researcher and lecturer at ISGA, he has witnessed the terrorist threat evolve and broaden. 'How can we explain these shifts and protect our society against them? That is what I want to focus on more,' he says.
-
Leila Akkari appointed Special Professor of Cancer–immune interactions
Leila Akkari was appointed Special Professor of Cancer-immune interactions at the Leiden Institute of Chemistry (LIC) on 15 December. Akkari is a researcher at the Netherlands Cancer Institute (NKI), where she studies the relationship between cancer cells and the immune system, with a particular focus…
-
Bart Custers in NRC on insurers' role in fraud cases
Insurers determine for themselves whether someone has committed fraud, impose sanctions immediately and hardly ever report it. As a result, police, prosecutors, and criminal courts are side-lined. And policyholders are sometimes left out in the cold. Bart Custers, professor of Law & Data Science at…
-
Bart Custers on BBC News about Uber’s Greyballing
In just over a decade, Uber has revolutionised how we move around our cities. The ride-hailing app was a game-changer: you just tapped your phone and a cab would find you. You even paid through the app. However, some of the Uber’s more controversial practices have triggered the interest of law enforcement,…
-
Bart Custers on insurance companies and fraud registers
Insurance companies are registering more and more people for having committed fraud. In principle, it is a good idea to tackle cases of fraud. However, research shows that an increasing number of people are being wrongly included on the fraud list. According to Bart Custers, Professor of Law & Data…
-
Bart Schermer: ‘Bedreigingen via internet zijn ook strafbaar’
Oostenrijk wil online bedreigingen en haat harder aanpakken. Aanleiding is de dood van huisarts Lisa-Maria Kellermayr. Zij maakte eind juli een einde aan haar leven, nadat ze maandenlang werd bedreigd door mensen die tegen coronamaatregelen en vaccinaties zijn.
-
Bart Barendregt on Unesco Chair in Anthropology of Digital Diversity
Bart Barendregt explains his new Unesco Chair in Anthropology of Digital Diversity in an interview on the Unesco website.
-
New potential cancer drugs and where to find them
Cancer research generates massive amounts of data, but traditional tools often fail to fully harness their potential. How can we unlock this data to provide better treatments for cancer patients? PhD candidate Marina Gorostiola González explored this by using advanced data analysis techniques to guide…
-
Bart Schermer appointed as Professor of Privacy and Cybercrime
As of 1 November 2021, Bart Willem Schermer has been appointed as Professor of Privacy and Cybercrime at eLaw – Center for Law and Digital Technologies.
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Bart Schermer on how to negotiate with cybercriminals
Hackers have got their hands on data from the Royal Dutch Football Association (KNVB). Lockbit, a collective of cybercriminals, is after the money. What now?
-
Bart Custers discusses fake news on facial recognition at Jumbo
Misleading social media posts are falsely claiming that the Dutch supermarket chain Jumbo uses facial recognition at self-service checkouts. Jumbo denies this, although it has launched trials with AI cameras to combat shoplifting without using facial recognition.
-
Bart Custers discusses arrest of Telegram CEO in 'Trouw'
Pavel Durov, CEO of chat and messaging app Telegram, was arrested in France last week. The Russian tech billionaire flew into Paris by private jet and was arrested on suspicion of cybercrimes. Telegram allegedly facilitates criminal activities such as money laundering. This raises the question of how…
-
KiKa grant for mathematician: how statistics helps fight bone cancer
Using mathematics to help children with bone cancer. It sounds a little strange, but for statistician Marta Fiocco, it's just her job. She gets a substantial grant from KiKa for it. With that money, she is going to study the effect of chemotherapy adjustments.
-
Anne Meuwese and Bart Custers in Trouw on Covid apps
The more people are vaccinated, the more society can slowly reopen. Technological developments, like the Covid passport and other apps, can play a role in this. Artificial Intelligence could help greatly in developing the vaccine passport and the Covid-19 exposure notification app, Anne Meuwese and…
-
Bart Custers writes blog post on judge who used ChatGPT
This month, it came out that a subdistrict court judge used ChatGPT to formulate a ruling. The judge included some text generated by the popular AI chatbot in his decision. This resulted in a lot of media commotion, raising doubts as to whether using ChatGPT in court is permissible and responsible.
-
Bart Schermer about attack on citizens' right to demonstrate
Media outlets Investico, de Groene Amsterdammer and Trouw reported on the wide-scale collection by the Dutch police of personal data of demonstrators and their family members. Bart Schermer, Professor of Privacy and Cybercrime, commented on the issue.
-
Bart Custers in Trouw on ChatGPT and cybercrime
The EU proposal for a regulatory framework on artificial intelligence will not prevent the dangers of cybercrime or the spreading of fake news using ChatGPT. Cyber criminals can use the new technology to write harmful software, phishing mails and fake news.
-
Bart Custers in Trouw about new European digital identity
Europe is working full steam towards a digital identity for every EU citizen. And although it might be really useful to be able to hire a car everywhere in the EU with no hassles, Bart Custers, Professor of Law and Data Science at eLaw, the Center for Law and Digital Technologies, sees many loose ends.…
-
Bart Custers on tech companies involved in criminal activities
Governments are increasingly cracking down on tech companies like X, Telegram and Clearview that flout the law, with a fine, ban or criminal prosecution. In practice, however, this has little effect. A tougher stance is needed, argues Bart Custers, Professor of Law and Data Science at eLaw – Center…
-
Synthetic Miniproteins Enter the Fight Against MYC-Driven Cancers
The transcription factor MYC is a master regulator implicated in the majority of human cancers. Despite its central role, MYC has long been considered "undruggable" by small molecules, lacking binding pockets and featuring disordered regions. While larger biomolecules could potentially disrupt MYC function,…
-
Bart Custers on using genealogical DNA in criminal cases
The Public Prosecutor's Office (OM) and the Netherlands Forensic Institute (NFI) want to use private DNA databases for genealogical research in criminal investigations. The method could be used in serious criminal cases that have stalled and it is already being used in investigations abroad. Whether…
-
Special nanoparticles for cancer therapy! Will you help?
Developing a better treatment for patients with head and neck cancer, that is what Binanox, The 2022 iGEM Leiden team, want to achieve. They hope to raise at least 10,000 euros for this cause. Support their crowdfunding campaign today.
-
Judith Bovéej.v.m.g.bovee@lumc.nl | 071 5269111
-
Professor Bart Schermer on digital threats to the university
Professor of Privacy and Cybercrime Bart Schermer researches the relationship between new digital technologies, enforcement and human rights. What cybercrime trends can he see that are relevant to an organisation like Leiden University?
-
Bart Barendregt appointed Dean of Faculty of Social and Behavioural Sciences
In consultation with the Executive Board of the Faculty of Social and Behavioural Sciences and having heard the views of the Faculty Council, the Executive Board has appointed Bart Barendregt as Dean of the Faculty until 1 April 2027.
-
Energy as a weak spot: a new approach to tackle aggressive breast cancer?
Could we stop cancer cells by cutting off their energy supply? That’s what Dione Blok, a bachelor’s student in Bio-Pharmaceutical Sciences, aimed to find out during her thesis research. She investigated a compound that affects the tumour cells’ energy metabolism. ‘Hopefully, these insights will provide…
-
Unlocking the secrets of DNA repair: Sarah’s curiosity might lead to new cancer treatments
How do cells repair their damaged DNA—and what happens when that process is hindered and cancer arises? Sarah Moser has taken a closer look during her PhD, uncovering surprising insights that could help improve future cancer treatments.
-
Bart de Smit reappointed as vice-dean at Leiden Science
The Executive Board has reappointed Professor of Algebra and Number Theory Bart de Smit as vice-dean at the Faculty of Science. De Smit had already held this position since the beginning of 2019. His term has been extended by four years until the end of 2026.
-
FAIR imaging for advancing science
Lecture, Tuesday Talk
-
Leiden joins EU effort to unite Europe’s cancer research networks
The more data from cancer research we pool, the better we can search for new treatments. But how can we keep patient data safe when sharing it? Leiden researchers will tackle this challenge in a major European project.
-
impact does communication have on individuals dealing with advanced cancer? Looking for participants
This study is important because it seeks to uncover whether clinicians' communication influences neurobiological and physiological outcomes for patients.
-
Bart Custers in De Jurist on UBO register and privacy legislation
Ultimate beneficial owners (UBOs) of companies should have registered their information in the Dutch UBO register before 27 March 2022. The Dutch Minister of Finance saw no reason to postpone the deadline for registration, according to answers to parliamentary questions. In an article on the legal platform…
-
Rietveld Award for innovative research on blood donation and colorectal cancer
One used 3D cell models to study colorectal cancer, while the other used machine learning for more efficient blood donation. For these achievements, Marieke Vinkenoog and Simon Christian Hansmann were awarded the Krijn Rietveld Memorial Innovation Award on Tuesday 2 September.
-
Chenlin Fengc.l.feng@lacdr.leidenuniv.nl | 071 5272727
-
Tailored solutions for older people with cancer: ‘We need to look at the individual’
Half of all people with cancer in the Netherlands are aged 70 or older, and as the population continues to age, this number will only rise. Yet vulnerable older people with cancer are often overlooked, says PhD candidate Joosje Baltussen.
-
National Growth Fund invests many millions in faster and more sustainable (cancer) drug development
On 14 April, the National Growth Fund awarded million euros in grants to two consortia in which Leiden's science faculty is involved. Pharma-NL will receive 80 million euros and Oncode-PACT 325 million euros. Pharma-NL wants to make medicines available to the patient faster and more sustainably. Oncode-PACT…
-
Alumnus Bart Jansen: ‘It’s up to us legal philosophers to make sense of these times’
Legal philosopher Bart Jansen teaches at universities around the world. In an interview two years ago, he spoke about his professional fascination for dictators and wars. Since then, the world has undergone major changes. High time for a follow-up interview.
-
Alumnus, rechtsfilosoof en wereldreiziger Bart Jansen: ‘focus je niet, maar verstrooi jezelf’
Stilzitten doet alumnus Bart Jansen niet graag. Zo geeft hij les in onder meer Nederland, Maleisië en Curaçao, houdt hij zich naast het recht ook graag bezig met kunst en mystiek en vindt hij naar eigen zeggen ‘alles wat fout gaat’ wel interessant aan de rechtsfilosofie. ‘Ik ben gek op veelzijdige mensen;…
-
Stiffness and viscosity of cells differ in cancer and other diseases
During illness, the stiffness or viscosity of cells can change. Tom Evers demonstrated this by measuring such properties of human immune cells for the first time. ‘The stiffness of certain cells could be a way to make a diagnosis,’ Evers said. He defended his thesis on March 26th.
-
Zuijderveldt won first prize in the ‘Schild-De Groen Onderzoeksprijzen' for cancer research
One of our PhD candidates at the LACDR, Joey Zuijdervelt, recently achieved recognition by winning the first prize in the ‘Schild-De Groen Onderzoeksprijzen’ for cancer research. His award-winning master’s thesis explored glioblastoma multiforme through an innovative orthotopic zebrafish xenograft model,…
-
receives ERC Proof of Concept grant for MYSTIC, to advance an innovative cancer treatment idea
Sebastian Pomplun from the Leiden Academic Centre for Drug Research has recently received an ERC Proof of Concept grant for his ambitious MYSTIC project. This initiative is set to transform cancer treatment by advancing the development of HeloMYC, a pioneering therapeutic candidate designed to target…
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Bart Barendregt receives Vici grant for research on Artificial Intelligence in Muslim Southeast Asia
Bart Barendregt receives a Vici grant of 1.5 million euros from the NWO for his research project 'One between the Zeros, an Anthropology of Artificial Intelligence in Islam'.
-
Contributing to cancer research in your own way: three PhD candidates on their work within Oncode Accelerator
Accelerating the development of new cancer medicines by joining forces—that’s the mission of Oncode Accelerator, a Dutch consortium that recently welcomed three Leiden-based PhD candidates. Under the guidance of Gerard van Westen, Marc Boef, Remco van den Broek, and Lucina-May Nollen are exploring how…
-
Sylvestre Bonnetbonnet@chem.leidenuniv.nl | 071 5274260
-
Bart Custers and Eduard Fosch-Villaronga examine the legal and ethical aspects of AI in radiology
Researchers at eLaw contribute to groundbreaking volume on AI in radiology, offering legal and ethical frameworks, governance models, and solutions for responsible clinical integration.